HEMATO-ONCOLOGIC PATIENTS

Clinical trials for HEMATO-ONCOLOGIC PATIENTS explained in plain language.

Never miss a new study

Get alerted when new HEMATO-ONCOLOGIC PATIENTS trials appear

Sign up with your email to follow new studies for HEMATO-ONCOLOGIC PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Faster blood recovery after cancer transplant? new drug combo shows promise

Disease control Recruiting now

This study is testing whether adding a drug called IL-11 to the standard drug G-CSF helps patients' blood cells recover more quickly after a stem cell transplant for blood cancers like multiple myeloma or lymphoma. The goal is to shorten the time patients have low platelet and re…

Matched conditions: HEMATO-ONCOLOGIC PATIENTS

Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

HEMATO-ONCOLOGIC PATIENTS

Get alerted when new HEMATO-ONCOLOGIC PATIENTS trials appear

Faster blood recovery after cancer transplant? new drug combo shows promise